These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Design and synthesis of pyridin-2-ylmethylaminopiperidin-1-ylbutyl amide CCR5 antagonists that are potent inhibitors of M-tropic (R5) HIV-1 replication. Skerlj R, Bridger G, Zhou Y, Bourque E, McEachern E, Langille J, Harwig C, Veale D, Yang W, Li T, Zhu Y, Bey M, Baird I, Sartori M, Metz M, Mosi R, Nelson K, Bodart V, Wong R, Fricker S, Mac Farland R, Huskens D, Schols D. Bioorg Med Chem Lett; 2011 Dec 01; 21(23):6950-4. PubMed ID: 22033460 [Abstract] [Full Text] [Related]
7. Synthesis and structure-activity relationships of phenylenebis(methylene)-linked bis-azamacrocycles that inhibit HIV-1 and HIV-2 replication by antagonism of the chemokine receptor CXCR4. Bridger GJ, Skerlj RT, Padmanabhan S, Martellucci SA, Henson GW, Struyf S, Witvrouw M, Schols D, De Clercq E. J Med Chem; 1999 Sep 23; 42(19):3971-81. PubMed ID: 10508445 [Abstract] [Full Text] [Related]
15. Anti-human immunodeficiency virus activity of novel aminoglycoside-arginine conjugates at early stages of infection. Cabrera C, Gutiérrez A, Blanco J, Barretina J, Litovchick A, Lapidot A, Evdokimov AG, Clotet B, Esté JA. AIDS Res Hum Retroviruses; 2000 May 01; 16(7):627-34. PubMed ID: 10791873 [Abstract] [Full Text] [Related]
16. Peptide-lead CXCR4 antagonists with high anti-HIV activity. Fujii N, Tamamura H. Curr Opin Investig Drugs; 2001 Sep 01; 2(9):1198-202. PubMed ID: 11717804 [Abstract] [Full Text] [Related]